Annual Net Income
-$145.22 M
+$180.77 M+55.45%
December 31, 2023
Summary
- As of February 7, 2025, DNLI annual net profit is -$145.22 million, with the most recent change of +$180.77 million (+55.45%) on December 31, 2023.
- During the last 3 years, DNLI annual net income has fallen by -$216.36 million (-304.15%).
- DNLI annual net income is now -304.15% below its all-time high of $71.14 million, reached on December 31, 2020.
Performance
DNLI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$107.19 M
-$8.17 M-8.25%
September 30, 2024
Summary
- As of February 7, 2025, DNLI quarterly net profit is -$107.19 million, with the most recent change of -$8.17 million (-8.25%) on September 30, 2024.
- Over the past year, DNLI quarterly net income has dropped by -$8.17 million (-8.25%).
- DNLI quarterly net income is now -143.77% below its all-time high of $244.88 million, reached on December 31, 2020.
Performance
DNLI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$427.49 M
-$7.84 M-1.87%
September 30, 2024
Summary
- As of February 7, 2025, DNLI TTM net profit is -$427.49 million, with the most recent change of -$7.84 million (-1.87%) on September 30, 2024.
- Over the past year, DNLI TTM net income has dropped by -$7.84 million (-1.87%).
- DNLI TTM net income is now -700.95% below its all-time high of $71.14 million, reached on December 31, 2020.
Performance
DNLI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
DNLI Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.5% | -8.3% | -1.9% |
| 3 y3 years | -304.1% | -8.6% | -31.1% |
| 5 y5 years | -300.7% | -8.6% | -31.1% |
DNLI Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.5% | -158.4% | +10.3% | -243.6% | at low |
| 5 y | 5-year | -304.1% | +55.5% | -143.8% | +10.3% | -701.0% | at low |
| alltime | all time | -304.1% | +55.5% | -143.8% | +10.3% | -701.0% | at low |
Denali Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$107.19 M(+8.2%) | -$427.49 M(+1.9%) |
| Jun 2024 | - | -$99.03 M(-2.7%) | -$419.65 M(+205.8%) |
| Mar 2024 | - | -$101.80 M(-14.8%) | -$137.25 M(-5.5%) |
| Dec 2023 | -$145.22 M(-55.5%) | -$119.47 M(+20.3%) | -$145.22 M(+16.7%) |
| Sep 2023 | - | -$99.35 M(-154.2%) | -$124.43 M(-3.1%) |
| Jun 2023 | - | $183.38 M(-267.0%) | -$128.38 M(-65.4%) |
| Mar 2023 | - | -$109.78 M(+11.3%) | -$370.55 M(+13.7%) |
| Dec 2022 | -$325.99 M(+12.2%) | -$98.68 M(-4.5%) | -$325.99 M(+7.7%) |
| Sep 2022 | - | -$103.30 M(+75.7%) | -$302.57 M(+6.6%) |
| Jun 2022 | - | -$58.79 M(-9.9%) | -$283.86 M(-0.7%) |
| Mar 2022 | - | -$65.22 M(-13.3%) | -$285.76 M(-1.7%) |
| Dec 2021 | -$290.58 M(-508.5%) | -$75.26 M(-11.0%) | -$290.58 M(-1082.9%) |
| Sep 2021 | - | -$84.59 M(+39.4%) | $29.57 M(-47.1%) |
| Jun 2021 | - | -$60.69 M(-13.3%) | $55.92 M(-3.3%) |
| Mar 2021 | - | -$70.04 M(-128.6%) | $57.86 M(-18.7%) |
| Dec 2020 | $71.14 M | $244.88 M(-520.6%) | $71.14 M(-131.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$58.23 M(-0.9%) | -$227.77 M(+5.5%) |
| Jun 2020 | - | -$58.76 M(+3.5%) | -$215.81 M(+0.2%) |
| Mar 2020 | - | -$56.76 M(+5.1%) | -$215.38 M(+9.0%) |
| Dec 2019 | -$197.61 M(+445.3%) | -$54.02 M(+16.8%) | -$197.61 M(+199.2%) |
| Sep 2019 | - | -$46.26 M(-20.7%) | -$66.06 M(+19.7%) |
| Jun 2019 | - | -$58.34 M(+49.6%) | -$55.17 M(+7.0%) |
| Mar 2019 | - | -$38.99 M(-150.3%) | -$51.55 M(+42.3%) |
| Dec 2018 | -$36.24 M(-58.9%) | $77.53 M(-319.2%) | -$36.24 M(-73.5%) |
| Sep 2018 | - | -$35.37 M(-35.4%) | -$136.66 M(+11.0%) |
| Jun 2018 | - | -$54.72 M(+131.1%) | -$123.13 M(+36.0%) |
| Mar 2018 | - | -$23.68 M(+3.5%) | -$90.54 M(+2.7%) |
| Dec 2017 | -$88.19 M(+1.8%) | -$22.89 M(+4.8%) | -$88.19 M(+4.2%) |
| Sep 2017 | - | -$21.84 M(-1.3%) | -$84.65 M(+34.8%) |
| Jun 2017 | - | -$22.13 M(+3.8%) | -$62.81 M(+54.4%) |
| Mar 2017 | - | -$21.32 M(+10.2%) | -$40.67 M(+110.2%) |
| Dec 2016 | -$86.65 M(+416.2%) | -$19.35 M | -$19.35 M |
| Dec 2015 | -$16.79 M | - | - |
FAQ
- What is Denali Therapeutics annual net profit?
- What is the all time high annual net income for Denali Therapeutics?
- What is Denali Therapeutics annual net income year-on-year change?
- What is Denali Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Denali Therapeutics?
- What is Denali Therapeutics quarterly net income year-on-year change?
- What is Denali Therapeutics TTM net profit?
- What is the all time high TTM net income for Denali Therapeutics?
- What is Denali Therapeutics TTM net income year-on-year change?
What is Denali Therapeutics annual net profit?
The current annual net income of DNLI is -$145.22 M
What is the all time high annual net income for Denali Therapeutics?
Denali Therapeutics all-time high annual net profit is $71.14 M
What is Denali Therapeutics annual net income year-on-year change?
Over the past year, DNLI annual net profit has changed by +$180.77 M (+55.45%)
What is Denali Therapeutics quarterly net profit?
The current quarterly net income of DNLI is -$107.19 M
What is the all time high quarterly net income for Denali Therapeutics?
Denali Therapeutics all-time high quarterly net profit is $244.88 M
What is Denali Therapeutics quarterly net income year-on-year change?
Over the past year, DNLI quarterly net profit has changed by -$8.17 M (-8.25%)
What is Denali Therapeutics TTM net profit?
The current TTM net income of DNLI is -$427.49 M
What is the all time high TTM net income for Denali Therapeutics?
Denali Therapeutics all-time high TTM net profit is $71.14 M
What is Denali Therapeutics TTM net income year-on-year change?
Over the past year, DNLI TTM net profit has changed by -$7.84 M (-1.87%)